Company Data
MiNK Therapeutics Inc.
Ticker
INKT
Current Price
$7.03 1.01%
Market Cap
$28.0M
Price Target
Refer to Report
Volume
1.4K
52wk Range
$4.5601 - $13.79
Overview
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T cell therapies to treat cancer and other life-threatening illnesses.